Author:
Parvathaneni Vineela,Kulkarni Nishant S.,Gupta Vivek
Publisher
Springer International Publishing
Reference107 articles.
1. Rosen H, Abribat T. The rise and rise of drug delivery. Nat Rev Drug Discov. 2005 May;4(5):381–5.
2. Shmulewitz A, Langer R, Patton J. Convergence in biomedical technology. Nat Biotechnol. 2006 Mar;24(3):277.
3. Vaidya B, Parvathaneni V, Kulkarni NS, Shukla SK, Damon JK, Sarode A, et al. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer. Int J Biol Macromol. 2019 Feb;122:338–47.
4. Kulkarni NS, Parvathaneni V, Shukla SK, Barasa L, Perron JC, Yoganathan S, et al. Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment. Eur J Pharm Sci. 2019 May 15;133:145–59.
5. Rizvi SAA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2018 Jan;26(1):64–70.